In vivo evaluation of a novel format of a bivalent HER3-targeting and albumin- binding therapeutic affibody construct

2017 
Overexpression of human epidermal growth factor receptor 3 (HER3) is involved in resistance to several therapies for malignant tumours. Currently, several anti-HER3 monoclonal antibodies are under ...
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    51
    References
    14
    Citations
    NaN
    KQI
    []